Fate Therapeutics FATE
NASDAQ FATE
$2.37 -0.01 (-0.42%)
At close: Sep 30, 2026 · 4:00 PM EDT

Fate Therapeutics (FATE) Operating Margin (2012 - 2026)

Updated

Fate Therapeutics (FATE) recorded Operating Margin of -1495.39% in Q2 2026, up 443.15 percentage points from -1938.54% a year earlier and up 1045.03 percentage points from the prior quarter.

Analysis

Fate Therapeutics (FATE) Operating Margin (2012 - 2026) Analysis & Trends

On a TTM basis, Fate Therapeutics' Operating Margin came in at -2058.08% as of Jun 30, 2026, up 213.15 percentage points year-over-year; for FY2025, it came in at -2222.45%, down 679.82 percentage points from FY2024.

  • Annual Operating Margin has a five-year change of -1814.98 percentage points (FY2020 to FY2025).
  • Across earlier years, Operating Margin came in at -1542.63% in FY2024 (-1242.77 pp), -299.86% in FY2023 (+20.37 pp), -320.23% in FY2022 (+68.32 pp) and -388.56% in FY2021 (+18.91 pp).
  • The Q2 2026 figure is the highest quarterly Operating Margin since Q2 2024.
  • On a year-over-year basis, Operating Margin rose in four of the last eight quarters, with an average year-over-year change of +32.21 percentage points.
  • Peak year-over-year performance for Operating Margin in the last five years was a gain of 6040.06 percentage points in Q2 2024, against a drop of 6257.74 percentage points in Q2 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at -2540.42% (Q1 2026), -2536.23% (Q4 2025) and -1995.12% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 28.21%
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 37.86%
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -3.52%
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 32.97%
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 20.57%
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 34.95%
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -133.21%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 37.40%
10 Fate Therapeutics 277.73 Mn 277.73 Mn - -1,495.39%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1,495.39%
Mar 31, 2026 -2,540.42%
Dec 31, 2025 -2,536.23%
Sep 30, 2025 -1,995.12%
Jun 30, 2025 -1,938.54%
Mar 31, 2025 -2,534.07%
Dec 31, 2024 -3,319.78%
Sep 30, 2024 -1,703.87%
Jun 30, 2024 -665.73%
Mar 31, 2024 -2,652.88%
Dec 31, 2023 -2,868.44%
Sep 30, 2023 -2,637.81%
Jun 30, 2023 -6,705.79%
Mar 31, 2023 -48.48%
Dec 31, 2022 -145.23%
Sep 30, 2022 -576.67%
Jun 30, 2022 -448.05%
Mar 31, 2022 -404.40%
Dec 31, 2021 -406.48%
Sep 30, 2021 -383.99%
API Access

Fate Therapeutics Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=FATE&period=max&api_key=YOUR_API_KEY